PhD Studentship - Panoz Pharmaceutical Innovation (Gilmer)

Post Summary

To undertake a structured PhD in pharmaceutical innovation under the principal supervision of Professor John Gilmer with co-supervision from Professors Mantalaris and Long (Medicine) and Dr Kiefer Ramberg. The project is directed at the potential involvement of integrins in the cytoprotective effects of bile acids, with elucidation of the underlying mechanisms and potential to harness this with non-bile acid ligands in drug design for degenerative disorders where dysregulated cell death contributes to disease progression. The project will investigate the potential for these cytoprotective effects to be harnessed in the optimal production of therapeutic antibodies from genetically engineered cells that will of interest to the biotech industry. 

NOTE: Applicants must have been resident in an EU member state for 3 out of the last 5 years to be eligible for EU fees

Application Procedure

Applicants should email  

and will be sent link to preliminary application form. Applicants will be shortlisted for interviews which will take place after the closing date of 10th May 2024 

At Trinity, we are committed to equality, diversity, and inclusion. Trinity welcomes applications from all individuals, including those applicants with disabilities, those who may have had non-traditional career paths, those who have taken time out for reasons including family or caring responsibilities. We also welcome international applicants including those whom have been displaced due to war.

We are ranked 3rd in the world for gender equality (Times Higher Education Impact Rankings 2020) and we hold an Athena SWAN Bronze award, recognising our work to advance gender equality. The University is actively pursuing a Silver level award, which it has committed to achieving by 2025. Trinity is committed to supporting the work-life balance and to creating a family-friendly working environment